Hikma Pharmaceutical | HIK - EPS Earnings Per Share


Hikma Pharmaceutical reported $0.65 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024H1 Jun/2024 0.13 458.0000 Aug/08




Eps Change Date
Almirall EUR 0.07 0.03 Dec/2025
argenx SE USD 4.7 2.1 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Fresenius EUR 0.82 0.04 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Orion EUR 0.66 1.19 Mar/2026
Recordati EUR 0.73 0 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025